Comparison between bottom-up and top-down approaches in the estimation of measurement uncertainty
-
Jun Hyung Lee
Abstract
Background: Measurement uncertainty is a metrological concept to quantify the variability of measurement results. There are two approaches to estimate measurement uncertainty. In this study, we sought to provide practical and detailed examples of the two approaches and compare the bottom-up and top-down approaches to estimating measurement uncertainty.
Methods: We estimated measurement uncertainty of the concentration of glucose according to CLSI EP29-A guideline. Two different approaches were used. First, we performed a bottom-up approach. We identified the sources of uncertainty and made an uncertainty budget and assessed the measurement functions. We determined the uncertainties of each element and combined them. Second, we performed a top-down approach using internal quality control (IQC) data for 6 months. Then, we estimated and corrected systematic bias using certified reference material of glucose (NIST SRM 965b).
Results: The expanded uncertainties at the low glucose concentration (5.57 mmol/L) by the bottom-up approach and top-down approaches were ±0.18 mmol/L and ±0.17 mmol/L, respectively (all k=2). Those at the high glucose concentration (12.77 mmol/L) by the bottom-up and top-down approaches were ±0.34 mmol/L and ±0.36 mmol/L, respectively (all k=2).
Conclusions: We presented practical and detailed examples for estimating measurement uncertainty by the two approaches. The uncertainties by the bottom-up approach were quite similar to those by the top-down approach. Thus, we demonstrated that the two approaches were approximately equivalent and interchangeable and concluded that clinical laboratories could determine measurement uncertainty by the simpler top-down approach.
References
1. CLSI. Expression of measurement uncertainty in laboratory medicine; approved guideline. CLSI document EP29-A. Wayne, PA: Clinical and Laboratory Standards Institute, 2012.Search in Google Scholar
2. The International Organization for Standardization. Medical laboratories – requirements for quality and competence. ISO/TC 212/SC. International Standard ISO 15189. Geneva, Switzerland: ISO, 2012.Search in Google Scholar
3. Chen H, Zhang L, Bi X, Deng X. Two evaluation budgets for the measurement uncertainty of glucose in clinical chemistry. Korean J Lab Med 2011;31:167–71.10.3343/kjlm.2011.31.3.167Search in Google Scholar PubMed PubMed Central
4. Bercik Inal B, Koldas M, Inal H, Coskun C, Gumus A, Doventas Y. Evaluation of measurement uncertainty of glucose in clinical chemistry. Ann N Y Acad Sci 2007;1100:223–6.10.1196/annals.1395.023Search in Google Scholar PubMed
5. Ellison SL, Williams A, editors. Eurachem/CITAC guide: quantifying uncertainty in analytical measurement, 3rd ed. 2012. Available from: http://www.eurachem.org/index.php/publications/guides/quam. Accessed 5 October, 2014.Search in Google Scholar
6. BIPM, IEC, IFCC, ILAC, IUPAC, IUPAP, ISO, OIML (2012). International vocabulary of metrology – basic and general concepts and associated terms (VIM), 3rd ed. JCGM 200:2012. Available from: http://www.bipm.org/en/publications/guides/vim.html. Accessed 5 November, 2014.Search in Google Scholar
7. CLSI. Evaluation of precision performance of quantitative measurement methods; approved guideline, 2nd ed. Document EP5-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2004.Search in Google Scholar
8. Sadler WA. Variance function program (version 11.0). Available from: http://www.aacb.asn.au/professionaldevelopment/useful-tools/variance-function-program-version-110. Accessed 25 August, 2013.Search in Google Scholar
9. BIPM, IEC, IFCC, ILAC, IUPAC, IUPAP, ISO, OIML (2008). Evaluation of measurement data — guide to the expression of uncertainty in measurement. JCGM 100:2008. Available from: http://www.bipm.org/en/publications/guides/gum.html. Accessed 5 November, 2014.Search in Google Scholar
10. CLSI. Statistical quality control for quantitative measurement procedures: principles and definitions; approved guideline, 3rd ed. CLSI document C24-A3. Wayne, PA: Clinical and Laboratory Standards Institute, 2006.Search in Google Scholar
Supplemental Material
The online version of this article (DOI: 10.1515/cclm-2014-0801) offers supplementary material, available to authorized users.
©2015 by De Gruyter
Articles in the same Issue
- Frontmatter
- Editorial
- Personalized medicine: moving from simple theory to daily practice
- Evaluating and using innovative technologies: a lesson from Theranos?
- Review
- Emerging biomarkers in the detection and prognosis of prostate cancer
- Mini Review
- Could molecular assessment of calcium metabolism be a useful tool to early screen patients at risk for pre-eclampsia complicated pregnancy? Proposal and rationale
- Opinion Papers
- Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe
- Theranos phenomenon: promises and fallacies
- Clinical laboratories: production industry or medical services?
- Genetics and Molecular Diagnostics
- Role of JAK2 V617F mutation and aberrant expression of microRNA-143 in myeloproliferative neoplasms
- Direct identification of Gram-positive bacteria and resistance determinants from blood cultures using a microarray-based nucleic acid assay: in-depth analysis of microarray data for undetermined results
- General Clinical Chemistry and Laboratory Medicine
- Comparison between bottom-up and top-down approaches in the estimation of measurement uncertainty
- Role of vitamin D and sFlt-1/PlGF ratio in the development of early- and late-onset preeclampsia
- Adenosine deaminase, dipeptidyl peptidase-IV activities and lipid peroxidation are increased in the saliva of obese young adult
- PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer’s disease or vascular dementia
- Comparison of five automated hematology analyzers in a university hospital setting: Abbott Cell-Dyn Sapphire, Beckman Coulter DxH 800, Siemens Advia 2120i, Sysmex XE-5000, and Sysmex XN-2000
- Dacryocytes are a common morphologic feature of autoimmune and microangiopathic haemolytic anaemia
- Performance characteristics of a new automated method for measurement of anti-cyclic citrullinated peptide
- The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method
- Reference Values and Biological Variations
- Reference interval for immature platelet fraction on Sysmex XN hematology analyzer: a comparison study with Sysmex XE-2100
- Development of the first urinary reproductive hormone ranges referenced to independently determined ovulation day
- Cancer Diagnostics
- Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue
- Cardiovascular Diseases
- Elevated circulating levels of lipoprotein-associated phospholipase A2 in obese children
- Letters to the Editors
- Reporting of hemolysis index (HI) with laboratory results should be obligatory in newborns and infants
- Unmeasurably high chloride: a surrogate marker of thiocyanate poisoning identification
- Association between red cell distribution width and myocardial infarction in rheumatoid arthritis
- Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency
- Rapid diagnosis of cryptococcal meningitis by Türk staining
- A high selectivity and sensitivity analytical method for the analysis of 8-hydroxy-2′-deoxyguanosine in the urine of Alzheimer’s disease patients
- S100B protein concentration measurement according to two different immunoassays
Articles in the same Issue
- Frontmatter
- Editorial
- Personalized medicine: moving from simple theory to daily practice
- Evaluating and using innovative technologies: a lesson from Theranos?
- Review
- Emerging biomarkers in the detection and prognosis of prostate cancer
- Mini Review
- Could molecular assessment of calcium metabolism be a useful tool to early screen patients at risk for pre-eclampsia complicated pregnancy? Proposal and rationale
- Opinion Papers
- Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe
- Theranos phenomenon: promises and fallacies
- Clinical laboratories: production industry or medical services?
- Genetics and Molecular Diagnostics
- Role of JAK2 V617F mutation and aberrant expression of microRNA-143 in myeloproliferative neoplasms
- Direct identification of Gram-positive bacteria and resistance determinants from blood cultures using a microarray-based nucleic acid assay: in-depth analysis of microarray data for undetermined results
- General Clinical Chemistry and Laboratory Medicine
- Comparison between bottom-up and top-down approaches in the estimation of measurement uncertainty
- Role of vitamin D and sFlt-1/PlGF ratio in the development of early- and late-onset preeclampsia
- Adenosine deaminase, dipeptidyl peptidase-IV activities and lipid peroxidation are increased in the saliva of obese young adult
- PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer’s disease or vascular dementia
- Comparison of five automated hematology analyzers in a university hospital setting: Abbott Cell-Dyn Sapphire, Beckman Coulter DxH 800, Siemens Advia 2120i, Sysmex XE-5000, and Sysmex XN-2000
- Dacryocytes are a common morphologic feature of autoimmune and microangiopathic haemolytic anaemia
- Performance characteristics of a new automated method for measurement of anti-cyclic citrullinated peptide
- The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method
- Reference Values and Biological Variations
- Reference interval for immature platelet fraction on Sysmex XN hematology analyzer: a comparison study with Sysmex XE-2100
- Development of the first urinary reproductive hormone ranges referenced to independently determined ovulation day
- Cancer Diagnostics
- Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue
- Cardiovascular Diseases
- Elevated circulating levels of lipoprotein-associated phospholipase A2 in obese children
- Letters to the Editors
- Reporting of hemolysis index (HI) with laboratory results should be obligatory in newborns and infants
- Unmeasurably high chloride: a surrogate marker of thiocyanate poisoning identification
- Association between red cell distribution width and myocardial infarction in rheumatoid arthritis
- Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency
- Rapid diagnosis of cryptococcal meningitis by Türk staining
- A high selectivity and sensitivity analytical method for the analysis of 8-hydroxy-2′-deoxyguanosine in the urine of Alzheimer’s disease patients
- S100B protein concentration measurement according to two different immunoassays
